Elevance Health, Inc. ELV
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.77% | 0.54% | 0.75% | 12.00% | 13.53% |
| Total Other Revenue | 4.74% | 5.89% | 13.19% | -1.21% | 6.55% |
| Total Revenue | 1.42% | 1.40% | 2.64% | 9.48% | 12.33% |
| Cost of Revenue | -0.95% | 0.87% | 0.86% | 13.63% | 15.75% |
| Gross Profit | 8.58% | 2.91% | 7.27% | -2.17% | 3.07% |
| SG&A Expenses | 6.78% | 7.28% | 14.68% | 2.34% | 9.86% |
| Depreciation & Amortization | -34.57% | -25.17% | -27.74% | -8.89% | 32.79% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.62% | 2.18% | 3.87% | 10.85% | 14.47% |
| Operating Income | 23.51% | -12.61% | -15.28% | -38.96% | -26.11% |
| Income Before Tax | 27.60% | -15.49% | -17.63% | -64.52% | 2.40% |
| Income Tax Expenses | 105.94% | -11.86% | -11.26% | -271.50% | -40.00% |
| Earnings from Continuing Operations | 13.14% | -16.63% | -19.41% | 32.20% | 17.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1,000.00% | 1,000.00% | 500.00% | -80.00% | -75.00% |
| Net Income | 14.80% | -16.06% | -19.19% | 30.86% | 17.03% |
| EBIT | 23.51% | -12.61% | -15.28% | -38.96% | -26.11% |
| EBITDA | 18.14% | -11.48% | -14.20% | -29.10% | -20.80% |
| EPS Basic | 18.35% | -12.89% | -16.77% | 36.35% | 21.54% |
| Normalized Basic EPS | 35.14% | -11.58% | -14.87% | -54.78% | -30.01% |
| EPS Diluted | 17.86% | -13.08% | -16.75% | 36.35% | 22.02% |
| Normalized Diluted EPS | 34.76% | -11.71% | -14.80% | -54.78% | -29.77% |
| Average Basic Shares Outstanding | -3.00% | -3.64% | -2.92% | -4.02% | -3.71% |
| Average Diluted Shares Outstanding | -2.73% | -3.50% | -2.99% | -4.02% | -4.03% |
| Dividend Per Share | 0.58% | 0.58% | 0.58% | 4.91% | 4.91% |
| Payout Ratio | -0.15% | 0.15% | 0.21% | -0.23% | -0.14% |